Valeant undercuts psoriasis rivals with $3,500 Siliq price by Tracy Staton Friday, April 21, 2017 Valeant unveiled the sticker on its new psoriasis drug Siliq—and at $3,500 per month it’s the lowest for next-gen meds.
Amgen slaps Sanofi, Regeneron with Dupixent lawsuit by Tracy Staton Thursday, April 20, 2017 It was destined to happen: Amgen has sued Sanofi and Regeneron, claiming their newly approved Dupixent infringes one of its antibody patents.
